Patents Assigned to Glenpharma
  • Dextran formulations and method for treatment of inflammatory joint disorders
    Patent number: 5902800
    Abstract: This disclosure describes pharmaceutical compositions and a method for treatment of joint inflammation and pain bought about by e.g. arthritis, physical trauma, bacterial or viral infection. In one embodiment, the method comprises administration of a bimodal molecular weight dextran formulation comprising 0.2 to 32% w/v of a dextran fraction with average molecular weight between 30,000 and 110,000 daltons and 0.2 to 6% dextran with an average molecular weight between 500 and 3,000 daltons, into the joint of a warm blooded animal.
    Type: Grant
    Filed: March 27, 1998
    Date of Patent: May 11, 1999
    Assignee: Glenpharma
    Inventors: June Ha Green, Peter B. Buckley